LANE SALAZAR: Open Payments
NPI 1821419094 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,971 in 91 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $1,971
Food & beverage: $1,971
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $269 |
| PFIZER INC. | 14 | $244 |
| ABBVIE INC. | 19 | $242 |
| Amgen Inc. | 4 | $229 |
| Novartis Pharmaceuticals Corporation | 11 | $195 |
| Stryker Corporation | 1 | $121 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| ANI Pharmaceuticals, Inc. | 4 | $92 |
| Neurelis, Inc. | 3 | $69 |
| UCB, Inc. | 3 | $67 |
Products named: INGREZZA, NURTEC ODT, KESIMPTA, QULIPTA, FLOWTRIEVER, Symbravo, PURIFIED CORTROPHIN GEL, VALTOCO.
Industry payments across AR — which companies pay providers there.
